Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Applied DNA Sciences, Inc is a security & protection services business based in the US. Applied DNA Sciences shares (APDN) are listed on the NASDAQ and all prices are listed in US Dollars. Applied DNA Sciences employs 59 staff and has a trailing 12-month revenue of around USD$1.9 million.
|Latest market close||USD$6.57|
|52-week range||USD$2.52 - USD$13.08|
|50-day moving average||USD$6.6015|
|200-day moving average||USD$7.8891|
|Wall St. target price||USD$13.5|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.322|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-11)||-25.68%|
|1 month (2020-12-18)||27.33%|
|3 months (2020-10-16)||-14.68%|
|6 months (2020-07-17)||-38.77%|
|1 year (2020-01-17)||53.15%|
|2 years (2019-01-18)||1,366.52%|
|3 years (2018-01-18)||343.92%|
|5 years (2016-01-15)||126.55%|
|Revenue TTM||USD$1.9 million|
|Gross profit TTM||USD$1.2 million|
|Return on assets TTM||-105.12%|
|Return on equity TTM||-536.06%|
|Market capitalisation||USD$30.7 million|
TTM: trailing 12 months
There are currently 662,175 Applied DNA Sciences shares held short by investors – that's known as Applied DNA Sciences's "short interest". This figure is 47.3% up from 449,626 last month.
There are a few different ways that this level of interest in shorting Applied DNA Sciences shares can be evaluated.
Applied DNA Sciences's "short interest ratio" (SIR) is the quantity of Applied DNA Sciences shares currently shorted divided by the average quantity of Applied DNA Sciences shares traded daily (recently around 365842.54143646). Applied DNA Sciences's SIR currently stands at 1.81. In other words for every 100,000 Applied DNA Sciences shares traded daily on the market, roughly 1810 shares are currently held short.
However Applied DNA Sciences's short interest can also be evaluated against the total number of Applied DNA Sciences shares, or, against the total number of tradable Applied DNA Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Applied DNA Sciences's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Applied DNA Sciences shares in existence, roughly 120 shares are currently held short) or 0.1207% of the tradable shares (for every 100,000 tradable Applied DNA Sciences shares, roughly 121 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Applied DNA Sciences.
Find out more about how you can short Applied DNA Sciences stock.
We're not expecting Applied DNA Sciences to pay a dividend over the next 12 months.
Applied DNA Sciences's shares were split on a 1:40 basis on 1 November 2019. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Applied DNA Sciences shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Applied DNA Sciences shares which in turn could have impacted Applied DNA Sciences's share price.
Over the last 12 months, Applied DNA Sciences's shares have ranged in value from as little as $2.52 up to $13.08. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied DNA Sciences's is 1.4446. This would suggest that Applied DNA Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fortify brand protection efforts, and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide definitive real-time authentication of molecular tags in the field; and CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and non-diagnostic COVID-19 pooled surveillance testing to detect instances of COVID-19 in defined populations under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Everything we know about the Vacasa IPO, plus information on how to buy in.
Everything we know about the William Penn Bancorp IPO, plus information on how to buy in.
Everything we know about the Landos Biopharma Inc IPO, plus information on how to buy in.
Everything we know about the First High-School Education Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Knowlton Development Corp IPO, plus information on how to buy in.
Steps to owning and managing SASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SAIL, with 24-hour and historical pricing before you buy.
Steps to owning and managing SAF, with 24-hour and historical pricing before you buy.
Steps to owning and managing RDHL, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBFG, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.